Kelly D. Deck
2021
In 2021, Kelly D. Deck earned a total compensation of $2.2M as Chief Financial Officer at Inhibrx, a 280% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $82,500 |
|---|---|
| Option Awards | $1,780,313 |
| Salary | $330,000 |
| Other | $11,253 |
| Total | $2,204,066 |
Deck received $1.8M in option awards, accounting for 81% of the total pay in 2021.
Deck also received $82.5K in non-equity incentive plan, $330K in salary and $11.3K in other compensation.
Rankings
In 2021, Kelly D. Deck's compensation ranked 5,674th out of 12,415 executives tracked by ExecPay. In other words, Deck earned more than 54.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,674 out of 12,415 | 54th |
Division Manufacturing | 2,408 out of 5,508 | 56th |
Major group Chemicals And Allied Products | 1,047 out of 2,378 | 56th |
Industry group Drugs | 934 out of 2,099 | 56th |
Industry Biological Products, Except Diagnostic Substances | 228 out of 449 | 49th |
Source: SEC filing on April 13, 2022.
Deck's colleagues
We found three more compensation records of executives who worked with Kelly D. Deck at Inhibrx in 2021.